Search Results

There are 172411 results for: content related to: Hepatitis C virus infection: in vivo and in vitro models

  1. Hepatitis C virus core protein, lipid droplets and steatosis

    Journal of Viral Hepatitis

    Volume 15, Issue 3, March 2008, Pages: 157–164, P. Roingeard and C. Hourioux

    Version of Record online : 17 DEC 2007, DOI: 10.1111/j.1365-2893.2007.00953.x

  2. HCV drug discovery aimed at viral eradication

    Journal of Viral Hepatitis

    Volume 17, Issue 2, February 2010, Pages: 77–90, R. F. Schinazi, L. Bassit and C. Gavegnano

    Version of Record online : 18 DEC 2009, DOI: 10.1111/j.1365-2893.2009.01246.x

  3. You have free access to this content
    HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus

    Hepatology

    Volume 49, Issue 3, March 2009, Pages: 745–752, Norman M. Kneteman, Anita Y. M. Howe, Tiejun Gao, Jamie Lewis, Dan Pevear, Gary Lund, Donna Douglas, David F. Mercer, D. Lorne J. Tyrrell, Frederick Immermann, Inder Chaudhary, John Speth, Stephen A. Villano, John O'Connell and Marc Collett

    Version of Record online : 5 NOV 2008, DOI: 10.1002/hep.22717

  4. Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-α

    Journal of Viral Hepatitis

    Volume 16, Issue 7, July 2009, Pages: 506–512, S. Toma, T. Yamashiro, S. Arakaki, J. Shiroma, T. Maeshiro, K. Hibiya, N. Sakamoto, F. Kinjo, M. Tateyama and J. Fujita

    Version of Record online : 3 MAR 2009, DOI: 10.1111/j.1365-2893.2009.01102.x

  5. You have free access to this content
    Review article: specifically targeted anti-viral therapy for hepatitis C – a new era in therapy

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 1, July 2010, Pages: 14–28, C. M. Lange, C. Sarrazin and S. Zeuzem

    Version of Record online : 31 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04317.x

  6. You have full text access to this Open Access content
    Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor

    Cancer Science

    Volume 100, Issue 10, October 2009, Pages: 1943–1950, Kaku Goto, Koichi Watashi, Daisuke Inoue, Makoto Hijikata and Kunitada Shimotohno

    Version of Record online : 26 JUN 2009, DOI: 10.1111/j.1349-7006.2009.01263.x

  7. You have full text access to this OnlineOpen article
    Hepatitis C virus replicons: dinosaurs still in business?

    Journal of Viral Hepatitis

    Volume 16, Issue 1, January 2009, Pages: 1–9, I. Woerz, V. Lohmann and R. Bartenschlager

    Version of Record online : 8 OCT 2008, DOI: 10.1111/j.1365-2893.2008.01066.x

  8. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  9. The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 18, Issue 11, November 2011, Pages: 768–778, R. Iwata, B. Stieger, J. C. Mertens, T. Müller, K. Baur, P. Frei, J. Braun, A. Vergopoulos, I. V. Martin, J. Schmitt, O. Goetze, S. Bibert, P.-Y. Bochud, B. Müllhaupt, T. Berg, A. Geier and Swiss Hepatitis C Cohort Study Group

    Version of Record online : 15 AUG 2010, DOI: 10.1111/j.1365-2893.2010.01363.x

  10. Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: 120–127, J. Vermehren, S. Susser, C. M. Lange, N. Forestier, U. Karey, E. Hughes, R. Ralston, X. Tong, S. Zeuzem and C. Sarrazin

    Version of Record online : 1 MAR 2011, DOI: 10.1111/j.1365-2893.2011.01449.x

  11. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus

    Journal of Viral Hepatitis

    Volume 18, Issue 5, May 2011, Pages: 305–315, K. Morikawa, C. M. Lange, J. Gouttenoire, E. Meylan, V. Brass, F. Penin and D. Moradpour

    Version of Record online : 23 MAR 2011, DOI: 10.1111/j.1365-2893.2011.01451.x

  12. You have free access to this content
    Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 1709–1718, Simone Susser, Christoph Welsch, Yalan Wang, Markus Zettler, Francisco S. Domingues, Ursula Karey, Eric Hughes, Robert Ralston, Xiao Tong, Eva Herrmann, Stefan Zeuzem and Christoph Sarrazin

    Version of Record online : 4 AUG 2009, DOI: 10.1002/hep.23192

  13. You have free access to this content
    Poster Session 4: Hepatitis C: Preclinical Development

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1161A–1173A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27534

  14. You have free access to this content
    Experimental models for hepatitis C viral infection

    Hepatology

    Volume 50, Issue 5, November 2009, Pages: 1646–1655, Andre Boonstra, Luc J. W. van der Laan, Thomas Vanwolleghem and Harry L. A. Janssen

    Version of Record online : 24 JUN 2009, DOI: 10.1002/hep.23138

  15. You have free access to this content
    New HCV therapies on the horizon

    Clinical Microbiology and Infection

    Volume 17, Issue 2, February 2011, Pages: 122–134, J. Vermehren and C. Sarrazin

    Version of Record online : 20 JAN 2011, DOI: 10.1111/j.1469-0691.2010.03430.x

  16. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: e81–e88, L. Bachmetov, M. Gal-Tanamy, A. Shapira, M. Vorobeychik, T. Giterman-Galam, P. Sathiyamoorthy, A. Golan-Goldhirsh, I. Benhar, R. Tur-Kaspa and R. Zemel

    Version of Record online : 16 AUG 2011, DOI: 10.1111/j.1365-2893.2011.01507.x

  17. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  18. Positional effects and strand preference of RNA interference against hepatitis C virus target sequences

    Journal of Viral Hepatitis

    Volume 14, Issue 3, March 2007, Pages: 194–212, R. M. Smith, R. Smolic, M. Volarevic and G. Y. Wu

    Version of Record online : 3 AUG 2006, DOI: 10.1111/j.1365-2893.2006.00794.x

  19. You have free access to this content
    Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs

    EMBO reports

    Volume 4, Issue 6, June 2003, Pages: 602–608, Takanori Yokota, Naoya Sakamoto, Nobuyuki Enomoto, Yoko Tanabe, Makoto Miyagishi, Shinya Maekawa, Li Yi, Masayuki Kurosaki, Kazunari Taira, Mamoru Watanabe and Hidehiro Mizusawa

    Version of Record online : 9 MAY 2003, DOI: 10.1038/sj.embor.embor840

  20. RNA interference for antiviral therapy

    The Journal of Gene Medicine

    Volume 8, Issue 8, August 2006, Pages: 933–950, Mali Ketzinel-Gilad, Yosef Shaul and Eithan Galun

    Version of Record online : 16 JUN 2006, DOI: 10.1002/jgm.929